Your browser doesn't support javascript.
loading
A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187.
Chen, Eric X; Jonker, Derek J; Siu, Lillian L; McKeever, Karyn; Keller, Deborah; Wells, Julie; Hagerman, Linda; Seymour, Lesley.
Affiliation
  • Chen EX; Princess Margaret Cancer Centre, University Health Network, Room 5-719, 610 University Ave, Toronto, ON, Canada, M5G 2 M9. eric.chen@uhn.ca.
  • Jonker DJ; Ottawa Health Research Institute, Ottawa, ON, Canada.
  • Siu LL; Princess Margaret Cancer Centre, University Health Network, Room 5-719, 610 University Ave, Toronto, ON, Canada, M5G 2 M9.
  • McKeever K; Princess Margaret Cancer Centre, University Health Network, Room 5-719, 610 University Ave, Toronto, ON, Canada, M5G 2 M9.
  • Keller D; Ottawa Health Research Institute, Ottawa, ON, Canada.
  • Wells J; Ottawa Health Research Institute, Ottawa, ON, Canada.
  • Hagerman L; Canadian Cancer Trials Group, Kingston, ON, Canada.
  • Seymour L; Canadian Cancer Trials Group, Kingston, ON, Canada.
Invest New Drugs ; 34(4): 450-7, 2016 08.
Article in En | MEDLINE | ID: mdl-27075016

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Camptothecin / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2016 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Camptothecin / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2016 Type: Article